COMMUNIQUÉS West-GlobeNewswire

Novan to Present Integrated Data from Phase 3 Trials with SB204 for Treatment of Acne
13/02/2018
MORRISVILLE, N.C., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ) today announced that data from the Company’s two Phase 3 clinical trials and long-term safety trial with SB204 [...]
Achaogen to Host Conference Call and Webcast of Fourth Quarter and Year 2017 Financial Results on February 27, 2018
13/02/2018
SOUTH SAN FRANCISCO, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO ), a late-stage biopharmaceutical company discovering and developing innovative antibacterials addressing multi-drug resistant [...]
BioSig Technologies to Open Operations Center in Austin, Texas
13/02/2018
Santa Monica, CA, Feb. 13, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Fulgent Genetics to Announce Fourth Quarter and Full Year 2017 Financial Results on February 28, 2018
13/02/2018
TEMPLE CITY, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT ) (“Fulgent Genetics” or the “company”) today announced that it will release its fourth quarter and full year 2017 financial [...]
Athletes vs Epilepsy Ambassador and Pro Golfer Jeff Klauk to Host Two Charity Tournaments Benefitting Epilepsy
13/02/2018
LANDOVER, Md., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Don’t miss your shot to tee up with professional golfer Jeff Klauk as he hosts two Athletes vs Epilepsy Million Dollar Shootout golf tournaments this spring. The two [...]
Foamix Pharmaceuticals Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call & Webcast Scheduled for February 28
13/02/2018
REHOVOT, Israel, and BRIDGEWATER, N.J., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ: FOMX ), (“Foamix”), a clinical stage specialty pharmaceutical company focused on developing and [...]
Athenex Announces Recent Product Launches in 503B and Specialty Injectables Business Units
13/02/2018
BUFFALO, N.Y., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
The Celiac Disease Foundation Appoints New Member to Board of Directors
13/02/2018
LOS ANGELES, Feb. 13, 2018 (GLOBE NEWSWIRE) -- The Celiac Disease Foundation, the nation’s leading disease advocacy organization for celiac disease, announces the appointment of a new member to its Board of Directors. [...]
Nu-Med Plus Announces Keith L. Merrell as their full-time Chief Financial Officer and Secretary/Treasurer
13/02/2018
SALT LAKE CITY, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCBB: NUMD ), a medical device company which explores and develops medical applications of new disruptive technologies in the medical field, [...]
Progressive Care Breaks Record with Over 23,000 Prescriptions Filled in January 2018
13/02/2018
MIAMI, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announces record breaking month of January 2018. PharmCo, LLC filled over 23,000 prescriptions [...]
Pain Therapeutics Resubmits New Drug Application for REMOXY® ER, an Abuse-Deterrent, Extended-Release Drug Candidate for the Treatment of Chronic Pain
13/02/2018
AUSTIN, Texas, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE ) announced today the resubmission to the U.S. Food and Drug Administration (FDA) of a New Drug Application (NDA) for REMOXY ® ER, [...]
Tyme to Present at RBC Capital Markets 2018 Global Healthcare Conference
13/02/2018
NEW YORK, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ), a clinical-stage biotechnology company developing cancer therapeutics, today announced that company management will present at the RBC [...]
PositiveID’s Thermomedics Delivers First 500 Caregiver Bluetooth Thermometers to Global Healthcare Company
13/02/2018
DELRAY BEACH, Fla., Feb. 13, 2018 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today that its Thermomedics [...]
Connexion Health Launches by Unveiling a Health and Fitness Platform for the 21st Century; Sacramento Kings Are First NBA Team to Announce Use of High-Tech Kiosk
13/02/2018
The Connexion platform, a walk-in kiosk powered by artificial intelligence and sensor technology combined with an extensive online marketplace for health and fitness apps, delivers unprecedented insights and [...]
Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
13/02/2018
DANVERS, Mass., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD ), a leading provider of breakthrough heart support and recovery technologies, announced today that it has received an expanded U.S. Food and [...]
Arch Biopartners Announces AB569 Phase I Human Trial Begins Patient Recruitment and Enrollment Stage
13/02/2018
TORONTO, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (Arch or the Company) (TSX Venture:ARCH) (OTCBB: ACHFF ) a portfolio based biotechnology company, announced today the investigator initiated phase I [...]
Annual General Meeting in ALK-Abelló A/S on 12 March 2018
13/02/2018
Copenhagen, 2018-02-13 13:55 CET (GLOBE NEWSWIRE) -- ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ): The annual general meeting of ALK-Abelló A/S will take place on Monday 12 March 2018 at 16:00 (CET) at ALK-Abelló A/S, 1 [...]
Spark Therapeutics to Host Conference Call on Tuesday, Feb. 20 at 8:30 a.m. ET to Discuss 2017 Results and Recent Business Highlights
13/02/2018
PHILADELPHIA, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE ), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, will host a conference call on [...]
KemPharm to Present at the RBC Capital Markets 2018 Global Healthcare Conference
13/02/2018
Corporate Updates and Clinical Progress to be Highlighted CORALVILLE, Iowa, Feb. 13, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH ), a clinical-stage specialty pharmaceutical company focused on the discovery [...]

Pages